SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-018044
Filing Date
2012-03-29
Accepted
2012-03-29 16:02:23
Documents
9
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v306088_10k.htm 10-K 687597
2 EXHIBIT 31 v306088_ex31.htm EX-31 10623
3 EXHIBIT 32 v306088_ex32.htm EX-32 4096
  Complete submission text file 0001144204-12-018044.txt   2371789

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT lixt-20111231.xml EX-101.INS 280814
5 XBRL TAXONOMY EXTENSION SCHEMA lixt-20111231.xsd EX-101.SCH 22501
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lixt-20111231_cal.xml EX-101.CAL 27411
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lixt-20111231_def.xml EX-101.DEF 66240
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lixt-20111231_lab.xml EX-101.LAB 151238
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lixt-20111231_pre.xml EX-101.PRE 87323
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-51476 | Film No.: 12723981
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences